DK1379650T3 - Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf - Google Patents
Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse herafInfo
- Publication number
- DK1379650T3 DK1379650T3 DK01988772T DK01988772T DK1379650T3 DK 1379650 T3 DK1379650 T3 DK 1379650T3 DK 01988772 T DK01988772 T DK 01988772T DK 01988772 T DK01988772 T DK 01988772T DK 1379650 T3 DK1379650 T3 DK 1379650T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- preferred
- preferred segments
- neural protein
- sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/697,590 US7259232B1 (en) | 2000-10-27 | 2000-10-27 | Preferred segments of neural thread protein |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1379650T3 true DK1379650T3 (da) | 2006-10-23 |
Family
ID=24801714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01988772T DK1379650T3 (da) | 2000-10-27 | 2001-10-25 | Foretrukne segmenter af neurale proteintråde samt fremgangsmåder til anvendelse heraf |
Country Status (15)
Country | Link |
---|---|
US (2) | US7259232B1 (de) |
EP (2) | EP1702985A3 (de) |
JP (1) | JP2005512500A (de) |
KR (1) | KR100843792B1 (de) |
CN (1) | CN1492926A (de) |
AT (1) | ATE330011T1 (de) |
AU (1) | AU2002232392A1 (de) |
BR (1) | BR0114977A (de) |
CA (1) | CA2427070A1 (de) |
CY (1) | CY1105380T1 (de) |
DE (1) | DE60120782T2 (de) |
DK (1) | DK1379650T3 (de) |
ES (1) | ES2266296T3 (de) |
PT (1) | PT1379650E (de) |
WO (1) | WO2002034915A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002302239B2 (en) * | 2000-10-27 | 2006-12-14 | Nymox Corporation | Method of preventing cell death using segments of neural thread proteins |
KR20040008177A (ko) * | 2001-05-16 | 2004-01-28 | 니목스 코포레이션 | 신경 사 단백질 세그먼트를 사용하여 세포 사멸을억제하는 방법 |
EP1541166B1 (de) * | 2001-05-16 | 2007-12-19 | Nymox Corporation | Prävention des Zelltodes durch Verwendung von Segmenten der Neurofilamentproteinen |
NZ529911A (en) * | 2001-05-25 | 2008-05-30 | Nymox Corp | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0068375A3 (de) | 1981-06-22 | 1983-04-13 | G.D. Searle & Co. | Rekombinante DNS Technik zur Herstellung von Relaxin |
SE8300693L (sv) | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5084559A (en) | 1987-03-27 | 1992-01-28 | Repligen Corporation | Protein a domain mutants |
CA2006332C (en) | 1988-12-21 | 2003-04-08 | Suzanne De La Monte | Method of detecting neurological disease or dysfunction |
US5948634A (en) | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
KR100374449B1 (ko) * | 1994-03-07 | 2003-09-06 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | 효소를인코우드하는디엔에이(dna),재조합디엔에이(dna)와효소,형질전환체및이들의제조방법과용도 |
GB9422175D0 (en) | 1994-11-03 | 1994-12-21 | Univ Dundee | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof |
US5958416A (en) | 1994-12-16 | 1999-09-28 | Regents Of The University Of Minnesota | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
US6610506B1 (en) * | 1995-12-01 | 2003-08-26 | University Technologies International, Inc. | Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same |
US6013763A (en) | 1996-06-04 | 2000-01-11 | Genentech, Inc. | Peptide variants of protein A |
WO1999016710A1 (en) | 1997-09-30 | 1999-04-08 | Cel-Sci Corporation | Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
US6399075B1 (en) | 1998-07-02 | 2002-06-04 | President And Fellows Of Harvard College | Compositions and methods for treating Papillomavirus-infected cells |
JP2002542766A (ja) | 1999-03-12 | 2002-12-17 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 50個のヒト分泌タンパク質 |
CA2368927A1 (en) | 1999-03-26 | 2000-10-05 | Craig A. Rosen | 45 human secreted proteins |
KR20040008177A (ko) | 2001-05-16 | 2004-01-28 | 니목스 코포레이션 | 신경 사 단백질 세그먼트를 사용하여 세포 사멸을억제하는 방법 |
-
2000
- 2000-10-27 US US09/697,590 patent/US7259232B1/en not_active Expired - Lifetime
-
2001
- 2001-10-25 DE DE60120782T patent/DE60120782T2/de not_active Expired - Lifetime
- 2001-10-25 CN CNA018212131A patent/CN1492926A/zh active Pending
- 2001-10-25 PT PT01988772T patent/PT1379650E/pt unknown
- 2001-10-25 JP JP2002537885A patent/JP2005512500A/ja active Pending
- 2001-10-25 KR KR1020037005830A patent/KR100843792B1/ko not_active IP Right Cessation
- 2001-10-25 ES ES01988772T patent/ES2266296T3/es not_active Expired - Lifetime
- 2001-10-25 WO PCT/US2001/042813 patent/WO2002034915A2/en active IP Right Grant
- 2001-10-25 BR BRPI0114977-6A patent/BR0114977A/pt not_active IP Right Cessation
- 2001-10-25 AU AU2002232392A patent/AU2002232392A1/en not_active Abandoned
- 2001-10-25 AT AT01988772T patent/ATE330011T1/de not_active IP Right Cessation
- 2001-10-25 EP EP06115298A patent/EP1702985A3/de not_active Withdrawn
- 2001-10-25 DK DK01988772T patent/DK1379650T3/da active
- 2001-10-25 CA CA002427070A patent/CA2427070A1/en not_active Abandoned
- 2001-10-25 EP EP01988772A patent/EP1379650B1/de not_active Expired - Lifetime
-
2006
- 2006-09-12 CY CY20061101300T patent/CY1105380T1/el unknown
-
2007
- 2007-07-23 US US11/878,288 patent/US20090258426A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090258426A1 (en) | 2009-10-15 |
DE60120782T2 (de) | 2007-05-24 |
EP1702985A3 (de) | 2007-03-07 |
JP2005512500A (ja) | 2005-05-12 |
WO2002034915A3 (en) | 2003-11-20 |
CY1105380T1 (el) | 2010-04-28 |
KR100843792B1 (ko) | 2008-07-03 |
BR0114977A (pt) | 2006-05-09 |
KR20030067681A (ko) | 2003-08-14 |
ATE330011T1 (de) | 2006-07-15 |
DE60120782D1 (de) | 2006-07-27 |
ES2266296T3 (es) | 2007-03-01 |
EP1702985A2 (de) | 2006-09-20 |
PT1379650E (pt) | 2006-10-31 |
US7259232B1 (en) | 2007-08-21 |
EP1379650A2 (de) | 2004-01-14 |
CA2427070A1 (en) | 2002-05-02 |
EP1379650B1 (de) | 2006-06-14 |
CN1492926A (zh) | 2004-04-28 |
WO2002034915A2 (en) | 2002-05-02 |
AU2002232392A1 (en) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE516304T1 (de) | Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden | |
CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
EA199900355A1 (ru) | Теломераза обратная тринскриптаза | |
ATE348157T1 (de) | Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren | |
AR006250A1 (es) | Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico | |
CY1113312T1 (el) | Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων | |
SE0103754L (sv) | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid | |
DE60323875D1 (de) | Eine atp-rückzykluslänge verwendende vorrichtung zur unterscheidung von arrythmien | |
DK0552240T3 (da) | Ny metode til behandling af depression | |
ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
ATE389881T1 (de) | Detektion von kleinen molekülen mit piezo- elektrischem sensor | |
BR0113099A (pt) | Gene e proteìna relacionados com esquizofrenia | |
DE69626522D1 (de) | Peptide mit pronociceptiveigenschaften | |
WO2002000719A3 (en) | Human and mouse g-protein couipled receptors | |
SE9701228D0 (sv) | Rekombinanta protein-C-och protein-S-varianter | |
ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
EP0816498A3 (de) | Exzitatorische Aminosäure Rezeptor-Protein und verwante Nukleinsäure | |
DE60139458D1 (de) | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide | |
BR9914090A (pt) | ácidos nucléicos codificando uma sub-unidade gama da proteìna g envolvida em transdução sensorial | |
DK0779297T3 (da) | Antigene peptider med glycinsubstitutioner | |
PT524421E (pt) | Herpesvirus humano tipo 6 proteina p 100, sequencias de adn correspondentes, preparacao e utilizacao | |
DE59914155D1 (de) | Neue peptidfragmente zur reinigung von proteinen | |
ATE414154T1 (de) | Moraxella (branhamella) catarrhalis antigene | |
ATE397753T1 (de) | Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung | |
DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide |